Profil is the world’s premier CRO in metabolic research. As a full-service provider, we conduct early phase clinical trials and we offer an unrivaled combination of science and professional conduct.
Our in-house scientific expertise covers pharmacology, obesity and (pre)diabetes, nutritional sciences, cardiometbolic research, hepatology, endocrinology, the entire spectrum of diabetes complications, cell and molecular biology as well as metabolic monitoring and medical technology.
One of our core technologies is the glucose clamp method, used to address action profiles of insulin and insulin analogues, beta cell function and insulin sensitivity. To be able to offer the best services for any glucose clamping setup, we have developed ClampArt, the next generation of glucose clamping.
Our up-to-date database with over 27.000 well characterized volunteers allows us to recruit even the most complex clinical trials at speeds that set the benchmark in the industry.
Profil offers early phase clinical trials in the areas of diabetes, prediabetes, NASH and obesity.
We also offer stand alone data management services for clinical trials as well as IMP manufacturing and logistics services for clinical trials run in Europe.